131 related articles for article (PubMed ID: 33841520)
1. Histone Deacetylase Inhibitory and Cytotoxic Activities of the Constituents from the Roots of
Soltani S; Boozari M; Nejad Ebrahimi S; Amin GR; Iranshahi M
Iran J Pharm Res; 2020; 19(4):51-58. PubMed ID: 33841520
[TBL] [Abstract][Full Text] [Related]
2. Absolute configuration and anti-cancer effect of prenylated flavonoids and flavonostilbenes from Sophora pachycarpa: Possible involvement of Wnt signaling pathway.
Boozari M; Nejad Ebrahimi S; Soltani S; Tayarani-Najaran Z; Emami SA; Asili J; Iranshahi M
Bioorg Chem; 2019 Apr; 85():498-504. PubMed ID: 30802806
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitory and cytotoxic activities of the constituents from the roots of three species of
Soltani S; Amin G; Salehi-Sourmaghi MH; Iranshahi M
Iran J Basic Med Sci; 2019 Jan; 22(1):93-98. PubMed ID: 30944714
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents.
Abdizadeh T; Kalani MR; Abnous K; Tayarani-Najaran Z; Khashyarmanesh BZ; Abdizadeh R; Ghodsi R; Hadizadeh F
Eur J Med Chem; 2017 May; 132():42-62. PubMed ID: 28340413
[TBL] [Abstract][Full Text] [Related]
5. Dereplication of cytotoxic compounds from different parts of Sophora pachycarpa using an integrated method of HPLC, LC-MS and
Shour S; Iranshahy M; Pham N; Quinn RJ; Iranshahi M
Nat Prod Res; 2017 Jun; 31(11):1270-1276. PubMed ID: 27696895
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity.
Trivedi P; Adhikari N; Amin SA; Bobde Y; Ganesh R; Jha T; Ghosh B
Eur J Pharm Sci; 2019 Oct; 138():105046. PubMed ID: 31421254
[TBL] [Abstract][Full Text] [Related]
7. In-vitro Evaluation of Cytotoxic and Apoptogenic Properties of Sophora Pachycarpa.
Mousavi SH; Motaez M; Zamiri-Akhlaghi A; Emami SA; Tayarani-Najaran Z
Iran J Pharm Res; 2014; 13(2):665-73. PubMed ID: 25237363
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
Xie R; Yao Y; Tang P; Chen G; Liu X; Yun F; Cheng C; Wu X; Yuan Q
Eur J Med Chem; 2017 Jul; 134():1-12. PubMed ID: 28391133
[TBL] [Abstract][Full Text] [Related]
9. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK
Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
[TBL] [Abstract][Full Text] [Related]
11. Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.
Zhao C; Zang J; Ding Q; Inks ES; Xu W; Chou CJ; Zhang Y
Eur J Med Chem; 2018 Apr; 150():282-291. PubMed ID: 29533873
[TBL] [Abstract][Full Text] [Related]
12. In vitro Cytotoxic Activities and Molecular Mechanisms of Angelica shikokiana Extract and its Isolated Compounds.
Mira A; Shimizu K
Pharmacogn Mag; 2015 Oct; 11(Suppl 4):S564-9. PubMed ID: 27013795
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Evaluation of Novel 3/4-((Substituted benzamidophenoxy) methyl)-N-hydroxybenzamides/propenamides as Histone Deacetylase Inhibitors and Antitumor Agents.
Anh DT; Thuan NT; Hai PT; Huong LT; Yen NTK; Han BW; Park EJ; Choi YJ; Kang JS; Hue VTM; Han SB; Nam NH
Anticancer Agents Med Chem; 2019; 19(4):546-556. PubMed ID: 30426904
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinase inhibitory prenylated flavonoids from Sophora flavescens.
Kim SJ; Son KH; Chang HW; Kang SS; Kim HP
Biol Pharm Bull; 2003 Sep; 26(9):1348-50. PubMed ID: 12951485
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.
Jung HA; Yoon NY; Kang SS; Kim YS; Choi JS
J Pharm Pharmacol; 2008 Sep; 60(9):1227-36. PubMed ID: 18718128
[TBL] [Abstract][Full Text] [Related]
16. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M
Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening.
Liu J; Zhou J; He F; Gao L; Wen Y; Gao L; Wang P; Kang D; Hu L
Eur J Med Chem; 2020 Apr; 192():112189. PubMed ID: 32151834
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of ortho-aryl N-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors.
Huang WJ; Wang YC; Chao SW; Yang CY; Chen LC; Lin MH; Hou WC; Chen MY; Lee TL; Yang P; Chang CI
ChemMedChem; 2012 Oct; 7(10):1815-24. PubMed ID: 22907916
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of the antioxidant prenylated flavonoids from the roots of Sophora flavescens.
Jung HA; Jeong DM; Chung HY; Lim HA; Kim JY; Yoon NY; Choi JS
Biol Pharm Bull; 2008 May; 31(5):908-15. PubMed ID: 18451517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
